{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T04:22:16Z","timestamp":1748406136079,"version":"3.41.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T00:00:00Z","timestamp":1432166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00115-014-4223-3","type":"journal-article","created":{"date-parts":[[2015,5,19]],"date-time":"2015-05-19T12:03:43Z","timestamp":1432037023000},"page":"672-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Klassifikation von Gliomen","Classification of gliomas"],"prefix":"10.1007","volume":"86","author":[{"given":"D.","family":"Capper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Reifenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"4223_CR1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00401-013-1141-6","volume":"126","author":"Arita","year":"2013","unstructured":"Arita H, Narita Y, Fukushima S et al (2013) Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss. Acta Neuropathol 126:267\u2013276","journal-title":"Acta Neuropathol"},{"key":"4223_CR2","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1126\/science.1210557","volume":"333","author":"Bettegowda","year":"2011","unstructured":"Bettegowda C, Agrawal N, Jiao Y et al (2011) Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 333:1453\u20131455","journal-title":"Science"},{"key":"4223_CR3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","volume":"46","author":"Buczkowicz","year":"2014","unstructured":"Buczkowicz P, Hoeman C, Rakopoulos P et al (2014) Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations. Nat Genet 46:451\u2013456","journal-title":"Nat Genet"},{"key":"4223_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2012.43.2674","volume":"31","author":"Cairncross","year":"2013","unstructured":"Cairncross G, Wang M, Shaw E et al (2013) Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. J Clin Oncol 31:337\u2013343","journal-title":"J Clin Oncol"},{"key":"4223_CR5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","volume":"20","author":"Capper","year":"2010","unstructured":"Capper D, Weissert S, Balss J et al (2010) Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors. Brain Pathol 20:245\u2013254","journal-title":"Brain Pathol"},{"key":"4223_CR6","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","volume":"462","author":"Dang","year":"2009","unstructured":"Dang L, White DW, Gross S et al (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739\u2013744","journal-title":"Nature"},{"key":"4223_CR7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00401-010-0781-z","volume":"120","author":"Hartmann","year":"2010","unstructured":"Hartmann C, Hentschel B, Wick W et al (2010) Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol 120:707\u2013718","journal-title":"Acta Neuropathol"},{"key":"4223_CR8","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/glia.21165","volume":"59","author":"Huse","year":"2011","unstructured":"Huse JT, Phillips HS, Brennan CW (2011) Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia 59:1190\u20131199","journal-title":"Glia"},{"key":"4223_CR9","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00018-011-0898-9","volume":"69","author":"Jones","year":"2012","unstructured":"Jones DT, Gronych J, Lichter P et al (2012) MAPK pathway activation in pilocytic astrocytoma. Cell Mol Life Sci 69:1799\u20131811","journal-title":"Cell Mol Life Sci"},{"key":"4223_CR10","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ng.2682","volume":"45","author":"Jones","year":"2013","unstructured":"Jones DT, Hutter B, Jager N et al (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45:927\u2013932","journal-title":"Nat Genet"},{"key":"4223_CR11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/bpa.12111","volume":"24","author":"Koelsche","year":"2014","unstructured":"Koelsche C, Sahm F, Wohrer A et al (2014) BRAF-mutated pleomorphic xanthoastrocytoma is associated with temporal location, reticulin fiber deposition and CD34 expression. Brain Pathol 24:221\u2013229","journal-title":"Brain Pathol"},{"key":"4223_CR12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.jnen.0000263869.84188.72","volume":"66","author":"Kros","year":"2007","unstructured":"Kros JM, Gorlia T, Kouwenhoven MC et al (2007) Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p\/19q loss, and correlations with outcome. J Neuropathol Exp Neurol 66:545\u2013551","journal-title":"J Neuropathol Exp Neurol"},{"key":"4223_CR13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00401-010-0693-y","volume":"120","author":"Lawson","year":"2010","unstructured":"Lawson AR, Tatevossian RG, Phipps KP et al (2010) RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort. Acta Neuropathol 120:271\u2013273","journal-title":"Acta Neuropathol"},{"key":"4223_CR14","doi-asserted-by":"crossref","unstructured":"Louis DN, Ohgaki H, Wiestler OD et al (2007) WHO classification of tumors of the central nervous system. IARC, Lyon","DOI":"10.1007\/s00401-007-0243-4"},{"key":"4223_CR15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/bpa.12171","volume":"24","author":"Louis","year":"2014","unstructured":"Louis DN, Perry A, Burger P et al (2014) International Society Of Neuropathology \u2013 Haarlem consensus guidelines for nervous system tumor classification and grading. Brain Pathol 24:429\u2013435","journal-title":"Brain Pathol"},{"key":"4223_CR16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","volume":"17","author":"Noushmehr","year":"2010","unstructured":"Noushmehr H, Weisenberger DJ, Diefes K et al (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17:510\u2013522","journal-title":"Cancer Cell"},{"key":"4223_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature13109","volume":"506","author":"Parker","year":"2014","unstructured":"Parker M, Mohankumar KM, Punchihewa C et al (2014) C11orf95-RELA fusions drive oncogenic NF-kappaB signalling in ependymoma. Nature 506:451\u2013455","journal-title":"Nature"},{"key":"4223_CR18","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807\u20131812","journal-title":"Science"},{"key":"4223_CR19","first-page":"1175","volume":"145","author":"Reifenberger","year":"1994","unstructured":"Reifenberger J, Reifenberger G, Liu L et al (1994) Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145:1175\u20131190","journal-title":"Am J Pathol"},{"key":"4223_CR20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00401-014-1370-3","volume":"129","author":"Reuss","year":"2015","unstructured":"Reuss DE, Sahm F, Schrimpf D et al (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an \u201eintegrated\u201c diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129:133\u2013146","journal-title":"Acta Neuropathol"},{"key":"4223_CR21","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00401-014-1326-7","volume":"128","author":"Sahm","year":"2014","unstructured":"Sahm F, Reuss D, Koelsche C et al (2014) Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. Acta Neuropathol 128:551\u2013559","journal-title":"Acta Neuropathol"},{"key":"4223_CR22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22:425\u2013437","journal-title":"Cancer Cell"},{"key":"4223_CR23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.2012.43.2229","volume":"31","author":"Van","year":"2013","unstructured":"Van Den Bent MJ, Brandes AA, Taphoorn MJ et al (2013) Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol 31:344\u2013350","journal-title":"J Clin Oncol"},{"key":"4223_CR24","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1200\/JCO.2009.23.0805","volume":"27","author":"Weller","year":"2009","unstructured":"Weller M, Felsberg J, Hartmann C et al (2009) Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network. J Clin Oncol 27:5743\u20135750","journal-title":"J Clin Oncol"},{"key":"4223_CR25","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1200\/JCO.2009.23.6497","volume":"27","author":"Wick","year":"2009","unstructured":"Wick W, Hartmann C, Engel C et al (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874\u20135880","journal-title":"J Clin Oncol"},{"key":"4223_CR26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","volume":"13","author":"Wick","year":"2012","unstructured":"Wick W, Platten M, Meisner C et al (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13:707\u2013715","journal-title":"Lancet Oncol"},{"key":"4223_CR27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","volume":"10","author":"Wick","year":"2014","unstructured":"Wick W, Weller M, Van Den Bent M et al (2014) MGMT testing \u2013 the challenges for biomarker-based glioma treatment. Nat Rev Neurol 10:372\u2013385","journal-title":"Nat Rev Neurol"},{"key":"4223_CR28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00401-013-1156-z","volume":"126","author":"Wiestler","year":"2013","unstructured":"Wiestler B, Capper D, Holland-Letz T et al (2013) ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis. Acta Neuropathol 126:443\u2013451","journal-title":"Acta Neuropathol"},{"key":"4223_CR29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00401-014-1315-x","volume":"128","author":"Wiestler","year":"2014","unstructured":"Wiestler B, Capper D, Sill M et al (2014) Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma. Acta Neuropathol 128:561\u2013571","journal-title":"Acta Neuropathol"},{"key":"4223_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2011.07.007","volume":"20","author":"Witt","year":"2011","unstructured":"Witt H, Mack SC, Ryzhova M et al (2011) Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. Cancer Cell 20:143\u2013157","journal-title":"Cancer Cell"},{"key":"4223_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","volume":"19","author":"Xu","year":"2011","unstructured":"Xu W, Yang H, Liu Y et al (2011) Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19:17\u201330","journal-title":"Cancer Cell"},{"key":"4223_CR32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","volume":"360","author":"Yan","year":"2009","unstructured":"Yan H, Parsons DW, Jin G et al (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765\u2013773","journal-title":"N Engl J Med"},{"key":"4223_CR33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00401-015-1405-4","volume":"129","author":"Korshunov","year":"2015","unstructured":"Korshunov A, Ryzhova M, Hovestadt V et al (2015) Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers. Acta Neuropathol 129(5):669\u2013678","journal-title":"Acta Neuropathol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4223-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-014-4223-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-014-4223-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T01:07:57Z","timestamp":1748394477000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-014-4223-3"}},"subtitle":["Aktuelle Fortschritte und Perspektiven","Current progress and perspectives"],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["4223"],"URL":"https:\/\/doi.org\/10.1007\/s00115-014-4223-3","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"type":"print","value":"0028-2804"},{"type":"electronic","value":"1433-0407"}],"subject":[],"published":{"date-parts":[[2015,5,21]]}}}